|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 548.50 SEK | -0.54% |
|
-1.44% | -0.09% |
| 07-22 | SEB raises Medcap price target to 660 kronor (630), reiterates buy | FW |
| 07-21 | MedCap AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Company Valuation: MedCap AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 4,997 | 8,899 | 8,278 | 8,214 | - | - |
| Change | - | 78.07% | -6.99% | -0.77% | - | - |
| Enterprise Value (EV) 1 | 4,997 | 9,176 | 8,359 | 8,297 | 8,059 | 7,819 |
| Change | - | 83.61% | -8.9% | -0.74% | -2.87% | -2.98% |
| P/E | 29.1x | 42.9x | - | 32.3x | 27.5x | 24.2x |
| PBR | - | 6.95x | - | 4.79x | 4.07x | 3.49x |
| PEG | - | 2.1x | - | - | 1.6x | 1.8x |
| Capitalization / Revenue | - | 4.93x | 3.93x | 3.43x | 3.06x | 2.81x |
| EV / Revenue | - | 5.08x | 3.97x | 3.46x | 3x | 2.67x |
| EV / EBITDA | - | 23.7x | 18.3x | 15x | 12.8x | 11.3x |
| EV / EBIT | - | 33.7x | 27.6x | 22.4x | 18.4x | 16.3x |
| EV / FCF | - | 28.8x | 26.4x | 44.8x | 22.4x | 19x |
| FCF Yield | - | 3.47% | 3.79% | 2.23% | 4.45% | 5.26% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | 11.6 | 14 | - | 16.97 | 19.95 | 22.62 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | - | 1,807 | 2,108 | 2,398 | 2,686 | 2,927 |
| EBITDA 1 | - | 387.7 | 456.3 | 551.5 | 632 | 694 |
| EBIT 1 | - | 272.3 | 302.9 | 370 | 437 | 479.5 |
| Net income 1 | 172.2 | 207.4 | 219.8 | 258 | 319 | 356 |
| Net Debt 1 | - | 276.5 | 81.3 | 83 | -155 | -395.5 |
| Reference price 2 | 337.50 | 601.00 | 549.00 | 548.50 | 548.50 | 548.50 |
| Nbr of stocks (in thousands) | 14,807 | 14,807 | 15,078 | 14,976 | - | - |
| Announcement Date | 1/31/24 A | 1/31/25 A | 2/5/26 A | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 3.46x | 15.04x | - | 861M | |
| 29.04x | 12.09x | 19.99x | 1.67% | 39.69B | |
| 15.45x | 8.37x | 13.4x | 6.8% | 21.41B | |
| 17.48x | 8.84x | 14.43x | 3.39% | 17.47B | |
| 24.57x | 4.78x | 8.32x | 3.07% | 3.79B | |
| 7.51x | 0.91x | 4.9x | 4.99% | 1.24B | |
| 10.55x | 10.73x | 9.51x | 7.55% | 962M | |
| 10.29x | 8.36x | 8.35x | 6.15% | 800M | |
| 7.25x | 7.31x | 26.44x | 4.73% | 593M | |
| Average | 15.27x | 7.20x | 13.38x | 4.8% | 9.65B | |
| Weighted average by Cap. | 22.26x | 9.87x | 16.29x | 3.54% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- MCAP Stock
- Valuation MedCap AB
Select your edition
All financial news and data tailored to specific country editions
